Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-01-10 @ 11:57 PM
Study NCT ID:
NCT03376958
Status:
COMPLETED
Last Update Posted:
2019-07-25
First Post:
2017-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Sponsor:
Zhengzhou University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-27
First Submit QC Date:
None
Study First Post Date:
2017-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-24
Last Update Post Date:
2019-07-25
Last Update Post Date Type:
ACTUAL